Cencora/COR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Cencora
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Ticker
COR
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Conshohocken, United States
Employees
44,000
Website
www.cencora.com
Cencora Metrics
BasicAdvanced
$44B
Market cap
24.48
P/E ratio
$9.13
EPS
0.47
Beta
$1.99
Dividend rate
0.89%
Dividend yield
Price and volume
Market cap
$44B
Beta
0.47
Dividend rate
$1.99
Financial strength
Current ratio
0.887
Quick ratio
0.499
Long term debt to equity
437.85
Total debt to equity
427.821
Dividend payout ratio (TTM)
22.13%
Interest coverage (TTM)
9.11%
Management effectiveness
Return on assets (TTM)
2.79%
Return on equity (TTM)
213.15%
Valuation
Price to earnings (TTM)
24.48
Price to revenue (TTM)
0.16
Price to book
41.13
Price to tangible book (TTM)
-3.55
Price to free cash flow (TTM)
21.25
Dividend yield (TTM)
0.89%
Growth
Revenue change (TTM)
11.71%
Earnings per share change (TTM)
17.50%
3-year revenue growth
12.10%
3-year earnings per share growth
-20.74%
3-year dividend per share growth
4.98%
What the Analysts think about Cencora
Analyst Ratings
Majority rating from 17 analysts.
Cencora Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$67B
5.50%
Net income
$480M
10.13%
Profit margin
0.71%
4.41%
Cencora Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$2.60
$2.71
$3.50
$2.92
-
Expected
$2.57
$2.64
$3.29
$2.82
$2.79
Surprise
1.16%
2.77%
6.24%
3.56%
-
Cencora News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cencora stock?
Cencora (COR) has a market cap of $44B as of July 03, 2024.
What is the P/E ratio for Cencora stock?
The price to earnings (P/E) ratio for Cencora (COR) stock is 24.48 as of July 03, 2024.
Does Cencora stock pay dividends?
Yes, the Cencora (COR) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $1.99 and the yield is 0.89%. Cencora has a payout ratio of 22.13% on a trailing twelve-month basis.
When is the next Cencora dividend payment date?
The next Cencora (COR) dividend payment date is unconfirmed.
What is the beta indicator for Cencora?
Cencora (COR) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Cencora stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.